AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Sopharma AD

Regulatory Filings • Aug 23, 2023

2543_rns_2023-08-23_bf6609bc-fb6d-47d7-bee8-d2efd96b8c9c.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

Current report №94/2023 Dated August 23, 2023

NOTIFICATION

"Sopharma" AD (the Company) notifies that the transformation by merger of "Biopharm Engineering" AD into "Sopharma" AD has been entered in the Commercial Register with number 20230823133229 with which "Biopharm Engineering" AD was deleted without liquidation. The activity of "Biopharm Engineering" AD is completely transferred to "Sopharma" AD, and all the assets of the merging company are transferred to "Sopharma" AD, which becomes its universal legal successor.

Ognian Donev

RAPORT ODEBRANY: Raport UNI-EN przekazano do kancelarii Publiczna GPW. Data odebrania: 2023-08-21 13:40 Konto: ESSSOADVIA. Funkcja skrуtu dla paczki raportu (SHA) 571ab1c31080413912ea476e21f2783d08ef25fae6fd8001e8863827962d19ed